Differences in the reserpine-sensitive storage in vivo of 1-methyl-4-phenylpyridinium in rats and mice may explain differences in catecholamine toxicity to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
- 30 June 1994
- journal article
- research article
- Published by Elsevier in Neurotoxicology and Teratology
- Vol. 16 (3) , 277-281
- https://doi.org/10.1016/0892-0362(94)90049-3
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidasePublished by Elsevier ,2004
- Selective retention of MPP+ within the monoaminergic systems of the primate brain following MPTP administration: An in vivo autoradiographic studyNeuroscience, 1991
- Neuromelanin-containing neurons are selectively vulnerable in parkinsonismTrends in Pharmacological Sciences, 1988
- Fructose prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced ATP depletion and toxicity in isolated hepatocytesBiochemical and Biophysical Research Communications, 1988
- A Dopaminergic Cell Line Variant Resistant to the Neurotoxin 1‐Methyl‐4‐Phenyl‐1,2,3,6‐TetrahydropyridineJournal of Neurochemistry, 1987
- Selectivity of the Parkinsonian Neurotoxin MPTP: Toxic Metabolite MPP + Binds to NeuromelaninScience, 1986
- Amphetamine, but not reserpine, protects mice against dopaminergic neurotoxicity of MPTPNeuropharmacology, 1985
- IV. Differences in the metabolism of MPTP in the rodent and primate parallel differences in sensitivity to its neurotoxic effectsLife Sciences, 1985
- Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonismNature, 1984
- Dopaminergic Neurotoxicity of 1-Methyl-4-Phenyl-1,2,5,6-Tetrahydropyridine in MiceScience, 1984